This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Glaxosmithkline Biologicals Sa. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Leigh Anne Ihnken: Innovator in Glycosylation Enzymes
Introduction: Leigh Anne Ihnken is an accomplished inventor based in Collegeville, PA (US). She is currently associated with GlaxoSmithKline Biologicals SA, where she contributes to advancements in biotechnology. Despite having no granted patents, her work in the field of oligosaccharyltransferase enzymes showcases her innovative spirit and dedication to scientific research.
Latest Patent Applications: One of her notable patent applications is titled "Mutated PglB Oligosaccharyltransferase Enzymes." This application provides details on mutated PglB oligosaccharyltransferase enzymes that efficiently catalyze the transfer of a saccharide from a lipid carrier to an asparagine residue in a glycosylation motif on a protein. The application also includes polynucleotides encoding these mutated enzymes, host cells capable of expressing them, and methods for using these engineered enzymes to produce N-glycosylated proteins. Additionally, it discusses the N-glycosylated proteins made using the engineered PglB oligosaccharyltransferase enzymes.
Conclusion: Leigh Anne Ihnken's contributions to the field of biotechnology, particularly in glycosylation enzymes, reflect her commitment to innovation and scientific progress. Her work has the potential to impact various applications in protein engineering and therapeutic development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile